Rituxan injection drug use-results survey in ABO-incompatible kidney transplantation recipients
Latest Information Update: 06 Sep 2020
At a glance
- Drugs Rituximab (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical; Zenyaku Kogyo
- 03 Mar 2020 Status changed from recruiting to active, no longer recruiting.
- 20 Sep 2016 New trial record